Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.
Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...
The Alzheimer's disease competitive landscape report delivers important insights into approved as well as ongoing research on 240+ pipeline Alzheimer's disease drugs, clinical strategies, upcoming ...
In vivo CAR-T therapy requires durable, yet transient CAR expression coupled with efficient, T cell-specific delivery. This webinar will focus on how innovations in RNA design and next-generation ...
Seasoned legal and compliance executive brings global product launch, strategic transaction and international operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results